IP Library Granted Patent US 8,170,672
Granted Patent B2
US 8,170,672 · App. 12/467,988 · Granted May 1, 2012

Elongated implant having an external energy coupling

Assignee: Biotronik CRM Patent AG
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,170,672
App. No.
12/467,988
Granted
May 1, 2012
Kind
B2
Abstract

Electrotherapeutic implant for stimulation of body tissue, comprising at least two electrode poles ( 14 ) which are connected to electric feeder lines, a demodulation unit ( 22 ), at least one electric feeder line ( 20 ), which is designed as an antenna and contacts the demodulation unit ( 22 ), wherein the implant ( 10 ) is fabricated from one piece, can be affixed ( 16 ) at the treatment site and is equipped with a biocompatible insulation, whereby the components of the implant ( 10 ) are designed so that a therapeutic energy which can be injected from the outside over the antenna ( 20 ) during the treatment is delivered to the therapeutic target region without intermediate storage.

Claims (40)

1. An electrotherapeutic implant ( 10 ) for stimulation of body tissue, comprising:

at least one electric feeder line ( 20 );

at least two electrode poles ( 14 ) which are connected to the at least one electric feeder line ( 20 );

a demodulation unit ( 22 );

wherein the at least one electric feeder line ( 20 ) is configured as an antenna and is in contact with the demodulation unit ( 22 );

wherein the electrotherapeutic implant ( 10 ) comprises one piece configured as a closed external form and which is further configured to affix at a treatment site and wherein the electrotherapeutic implant ( 10 ) further comprises a biocompatible insulation; and,

at least one terminal ( 34 ) configured to electrically and mechanically connect with a heart pacemaker wherein said at least one terminal ( 34 ) is electrically coupled with said at least two electrode poles ( 14 ) and configured to remain coupled between said electrode poles ( 14 ) and heart pacemaker after implantation of said electrotherapeutic implant ( 10 );

wherein said electrotherapeutic implant ( 10 ) is configured to deliver therapeutic energy received from said pacemaker via said at least one terminal ( 34 ), and

from outside of the electrotherapeutic implant ( 10 ) over the antenna without storage of the therapeutic energy,

to treat a therapeutic target region via the at least two electrode poles ( 14 ).

2. The electrotherapeutic implant ( 10 ) according to claim 1 , further comprising an enable device ( 23 ) configured to allow delivery of the therapeutic energy via the at least two electrode poles ( 14 ) only when an enable code is received.

3. The electrotherapeutic implant ( 10 ) according to claim 2 , further comprising:

a second antenna ( 24 ) which is configured to

receive the enable code required to enable the at least two electrode poles ( 14 ) and/or

receive control signals; and,

wherein

an enable code signal frequency

differs from

a therapeutic energy frequency.

4. The electrotherapeutic implant ( 10 ) according to claim 3 , further comprising a control unit ( 30 ) that is configured to control a therapeutic sequence wherein a required energy to supply power to the control unit ( 30 ) is received over

the antenna that is configured to receive the therapeutic energy, or

the second antenna ( 24 ) that is configured to receive the control signals and/or the enable code.

5. The electrotherapeutic implant ( 10 ) according to claim 2 , wherein the enable code required to enable the at least two electrode poles ( 14 ) contains an implant-specific individual identifier.

6. The electrotherapeutic implant ( 10 ) according to claim 1 , further comprising a control unit ( 30 ) that is configured to control a therapeutic sequence.

7. The electrotherapeutic implant ( 10 ) according to claim 6 , further comprising a temporary energy storage mechanism that supplies power to the control unit ( 30 ) during the treatment.

8. The electrotherapeutic implant ( 10 ) according to claim 1 , having a ratio of longitudinal dimension to transverse dimension of greater than or equal to 10.

9. The electrotherapeutic implant ( 10 ) according to claim 1 , further comprising a control unit coupled with said at least one electric feeder line wherein said control unit is configured for placement within a body comprising the body tissue.

10. The electrotherapeutic implant ( 10 ) according to claim 1 , wherein the therapeutic energy received is delivered directly to the therapeutic target region with the antenna in contact with the demodulation unit ( 22 ) at a first end of the antenna and with the antenna in contact with one of the at least two electrode poles ( 14 ) at a second end of the antenna.

11. The electrotherapeutic implant ( 10 ) according to claim 1 , wherein the demodulation unit ( 22 ) is a diode.

12. The electrotherapeutic implant ( 10 ) according to claim 1 , further comprising:

a second antenna ( 24 ); and,

a measurement device ( 32 ) that is connected to the antenna or second antenna and wherein the measurement device ( 32 ) is configured to transmit patient-specific and/or device-specific measured data to the outside of the electrotherapeutic implant ( 10 ) over the antenna or second antenna.

13. A pulse generator for external supply of therapeutic energy to an electrotherapeutic implant according to claim 1 , comprising:

a high-frequency generator configured to generate a high-frequency alternating voltage;

at least one antenna over which the therapeutic energy is transmitted as the high-frequency alternating voltage; and,

a control unit configured to generate a control signal that contains information about a desired therapeutic sequence, and,

an enable code to enable the electrotherapeutic implant.

14. The pulse generator according to claim 13 , wherein the control unit is configured to receive and analyze and/or store patient-specific measured data and/or instrument-specific measured data sent by the electrotherapeutic implant wherein the electrotherapeutic implant further comprises:

a second antenna ( 24 ); and,

a measurement device ( 32 ) that is connected to the antenna or second antenna and wherein the measurement device ( 32 ) is configured to transmit patient-specific and/or device-specific measured data to the outside of the electrotherapeutic implant ( 10 ) over the antenna or second antenna.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 23, 2018
From: BIOTRONIK CRM PATENT AG
To: BIOTRONIK SE & CO. KG
Reel/Frame 045995/0948 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 18, 2009
From: WEISS, INGO, DR.; DOERR, THOMAS; NEUMANN, ANDREAS; FLACH, ERHARD; BURCH, ANDRE
To: BIOTRONIK CRM PATENT AG
Reel/Frame 023255/0863 →
Priority Claims (1)
DE 10 2008 002 228 · Jun 5, 2008 · national
Continuity (1)
Related Publication 20090306738A1 · Dec 10, 2009